Back
Blackrock Municipal Income Quality Trust Vs. Sarepta Therapeutics Industry Stock Comparison
Sell
29
BYM
Blackrock Municipal Income Quality Trust
Last Price:
11.61
Seasonality Move:
2.62%
Buy
60
SRPT
Sarepta Therapeutics
Last Price:
138.01
Seasonality Move:
14.88%
Sell
29
Blackrock Municipal Income Quality Trust (BYM)
is a Sell
Is Blackrock Municipal Income Quality Trust a Buy, Sell or Hold?
- The current Blackrock Municipal Income Quality Trust [BYM] share price is $11.60. The Score for BYM is 29, which is 42% below its historic median score of 50, and infers higher risk than normal.
- BYM is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
60
Sarepta Therapeutics (SRPT)
is a Buy
Is Sarepta Therapeutics a Buy, Sell or Hold?
- The current Sarepta Therapeutics [SRPT] share price is $137.94. The Score for SRPT is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
- SRPT is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
BYM Stock Price Chart
What is Blackrock Municipal Income Quality Trust's stock price today?
-
The Blackrock Municipal Income Quality Trust share price today is $11.60
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BYM is experiencing buying pressure, which is a positive indicator for future bullish movement.
SRPT Stock Price Chart
What is Sarepta Therapeutics's stock price today?
-
The Sarepta Therapeutics share price today is $137.94
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SRPT is experiencing buying pressure, which is a positive indicator for future bullish movement.
BYM Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.05 | Sell |
Relative Strength Index (14 RSI): | 55 | Buy |
Chaikin Money Flow: | 50912 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (11.37 - 11.53) | Buy |
Bollinger Bands (100): | (11.51 - 12.01) | Sell |
SRPT Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.37 | Sell |
Relative Strength Index (14 RSI): | 69.97 | Buy |
Chaikin Money Flow: | 2429824 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (110.85 - 129.69) | Buy |
Bollinger Bands (100): | (119.21 - 142.01) | Buy |
BYM Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 11.42 | Buy |
20-day SMA: | 11.44 | Buy |
50-day SMA: | 11.69 | Sell |
200-day SMA: | 11.54 | Buy |
8-day EMA: | 11.47 | Buy |
20-day EMA: | 11.49 | Buy |
50-day EMA: | 11.61 | Sell |
200-day EMA: | 11.52 | Buy |
SRPT Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 116.25 | Buy |
20-day SMA: | 117.78 | Buy |
50-day SMA: | 122.17 | Buy |
200-day SMA: | 130.04 | Buy |
8-day EMA: | 121.1 | Buy |
20-day EMA: | 119.12 | Buy |
50-day EMA: | 122.54 | Buy |
200-day EMA: | 126.1 | Buy |
Blackrock Municipal Income Quality Trust Earnings Growth & BYM Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates
- Analysts estimate an earnings increase this quarter of $2.75 per share, a decrease next quarter of $0.00 per share, an increase this year of $4.84 per share, and an increase next year of $7.74 per share.
Blackrock Municipal Income Quality Trust Technical Analysis
Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | Nov 25 | Nov 26 | Nov 27 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
14 | 15 | 18 | 19 | 20 | 21 | 22 | 25 | 26 | 27 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Sarepta Therapeutics Technical Analysis
Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | Nov 25 | Nov 26 | Nov 27 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
14 | 15 | 18 | 19 | 20 | 21 | 22 | 25 | 26 | 27 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |